Expedition cruises, island hopping, and zoonotic risk: governance and operational lessons from the MV Hondius Andes hantavirus outbreak - Report - MDSpire

Expedition cruises, island hopping, and zoonotic risk: governance and operational lessons from the MV Hondius Andes hantavirus outbreak

  • By

  • Esteban Ortiz-Prado

  • María Paz Cadena

  • María A. Vethencourt-Ysea

  • Jorge Vasconez-Gonzalez

  • Kirk O. Douglas

  • Juan S. Izquierdo-Condoy

  • July 16, 2026

Share

Clinical Report: MV Hondius Andes Hantavirus Outbreak and Governance Lessons

Overview

The Andes orthohantavirus outbreak linked to the MV Hondius cruise resulted in 13 cases and 3 deaths, highlighting governance and operational gaps in managing zoonotic risks during expedition travel.

Background

The MV Hondius outbreak serves as a case study in zoonotic diseases and international travel. Hantavirus infections, typically associated with rodent exposure, can escalate into public health crises in mobile and enclosed environments.

Data Highlights

MetricValue
Reported Cases13
Deaths3
Case Fatality Ratio25%
Countries Under Monitoring30
Contacts Traced600+

Key Findings

  • The outbreak involved 13 reported cases and 3 deaths aboard the MV Hondius.
  • Initial exposure was likely land-based, with potential person-to-person transmission documented in some cases.
  • WHO assessed the global risk as low but maintained a precautionary monitoring period of 42 days.
  • Existing health regulations and guidelines were found insufficient for expedition-specific scenarios.
  • A One Health preparedness model was proposed to address identified operational gaps.

Clinical Implications

Healthcare professionals should be aware of zoonotic diseases in travel settings, particularly in enclosed environments.

Conclusion

The MV Hondius outbreak illustrates the need for addressing governance and operational gaps in managing zoonotic risks in international travel.

Related Resources & Content

  1. WHO, Disease Outbreak News, 2026 -- Hantavirus outbreak linked to cruise ship travel
  2. ECDC, Rapid Scientific Advice, 2026 -- Management of passengers
  3. CDC, Interim Guidance, 2026 -- Public Health Assessment for Andes Virus
  4. International Journal of Infectious Diseases — Outbreak at Sea: The MV Hondius Hantavirus Cluster as a Sentinel for Global Pandemic Readiness
  5. International Journal of Infectious Diseases — When rare zoonoses travel: Andes virus, hantavirus cardiopulmonary syndrome, and the preparedness gap
  6. Stat News — Key takeaways from WHO briefing on hantavirus cruise ship outbreak
  7. Stat News — The cruise ship hantavirus outbreak is a warning sign to the U.S.
  8. Outbreak at Sea: The MV Hondius Hantavirus Cluster as a Sentinel for Global Pandemic Readiness
  9. When rare zoonoses travel: Andes virus, hantavirus cardiopulmonary syndrome, and the preparedness gap
  10. Key takeaways from WHO briefing on hantavirus cruise ship outbreak
  11. Hantavirus outbreak linked to cruise ship travel, Multi-locations
  12. Rapid Scientific Advice on the management of passengers
  13. Interim Guidance for Public Health Assessment and Management of People with Potential Exposure to Andes Virus | Hantavirus | CDC
  14. Laboratory testing of Andes virus (Orthohantavirus andesense) infection: interim guidance, 15 May 2026
  15. https://www.ecdc.europa.eu/sites/default/files/documents/andes-virus-rapid-scientificp-advice-laboratory-testing-high-risk-contacts-Hondius-outbreak.pdf
  16. Hantavirus cardiopulmonary syndrome: organ support requirements and outcomes from a national Chilean cohort | Critical Care | Springer Nature Link
  17. Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America - PubMed
  18. High-Dose Intravenous Methylprednisolone for Hantavirus Cardiopulmonary Syndrome in Chile: A Double-Blind, Randomized Controlled Clinical Trial - PMC
  19. A non-randomized multicentre trial of human immune plasma for treatment of hantavirus cardiopulmonary syndrome caused by Andes virus - PubMed
  20. Infection prevention and control of hantavirus infection, including Andes virus disease. Interim regional guidance for suspected or confirmed cases - PAHO/WHO | Pan American Health Organization

Original Source(s)

Related Content